세계의 바이오세라믹 시장 보고서(2025년)
Bioceramics Global Market Report 2025
상품코드 : 1824596
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오세라믹 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.4%를 나타내 56억 2,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 생체활성 세라믹에 대한 수요 증가, 신경학에서의 용도의 확대, 치아의 건강에 대한 의식 증가, 의학연구에서의 국제공동연구, 개인화의료에 대한 주목 등에 기인하고 있습니다. 예측 기간의 주요 동향으로는 고급 3d 프린팅 기술의 출현, 다기능 바이오세라믹 재료의 개발, 바이오세라믹 설계에 있어서의 나노기술의 활용, 항균 바이오세라믹의 도입, 일시적 임플란트용의 생체 흡수성 바이오세라믹에 대한 주목, 임플란트용 바이오세라믹 코팅의 진보 등이 있습니다.

향후 5년간의 성장률 6.4%라고 하는 예측은 이 시장의 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 브라질과 독일에서 개발된 하이드록시아파타이트 뼈 이식편 및 치과용 임플란트 재료의 가격을 상승시켜 재건 수술 지연과 임플란트 수술 비용 상승을 초래하여 미국의 정형외과 수술에 지장을 줄 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

정형외과 및 치과 질환의 유병률 증가는 미래의 바이오세라믹 시장 성장을 이끌 것으로 예측됩니다. 정형외과 및 치과 질환은 두 가지 다른 유형의 병리학으로, 정형외과 질환은 주로 근골격계에 영향을 미치고, 치과 질환은 구강의 건강과 구강의 구조에 영향을 미칩니다. 바이오세라믹은 생체 적합성, 내구성 및 천연 뼈와 치아의 특성을 모방하는 능력으로 정형외과와 치과 모두에서 널리 사용됩니다. 정형외과에서는 인공 고관절이나 인공 슬관절 등의 임플란트로서 일반적으로 이용되고 있습니다. 마찬가지로 치과에서 바이오세라믹은 크라운, 브리지, 임플란트 등 다양한 치과 수복물에 널리 적용됩니다. 예를 들어 2022년 7월 공중보건기구인 UK Health Security는 2022년부터 2023년까지 회계연도에 정형외과 수술의 의무적 제출이 10.2% 증가하여 10만 2,025건에 달했다고 보고했습니다. 또한 2023년 3월 스위스에 본사를 둔 정부기관인 세계보건기구에 따르면 2022년에는 구강질환이 세계에서 약 35억 명에 영향을 미쳤습니다. 게다가 2024년 2월 영국을 거점으로 하는 건강 단체인 영국 치과 의사회는 영국에서는 1,200만명 이상의 성인이 해결되지 않은 치과 치료를 보유하고 있다고 보고했습니다. 따라서 정형외과 및 치과 질환의 유병률 증가는 바이오세라믹 시장을 밀어올릴 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Bioceramics represent a category of biomaterials composed of ceramic compounds, specifically engineered for applications in medical and healthcare settings, including the repair or replacement of damaged bone tissue, joints, and other organs.

The primary types of bioceramics include bioinert, bioactive, and bioresorbable. Bioinert characterizes materials or substances with minimal reactivity, and examples encompass aluminum oxide, zirconia, calcium phosphate, and others. These bioinert bioceramics find applications in various medical fields such as orthopedics, dental implants, biomedical applications, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The bioceramics market research report is one of a series of new reports from The Business Research Company that provides bioceramics market statistics, including bioceramics industry global market size, regional shares, competitors with a bioceramics market share, detailed bioceramics market segments, market trends and opportunities, and any further data you may need to thrive in the bioceramics industry. This bioceramics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioceramics market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.39 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing aging population, growing incidence of chronic diseases, demand for aesthetic dentistry, regulatory approvals and standards, increased focus on regenerative medicine.

The bioceramics market size is expected to see strong growth in the next few years. It will grow to $5.62 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising demand for bioactive ceramics, expanding applications in neurology, growing awareness of dental health, international collaborations in medical research, focus on personalized medicine. Major trends in the forecast period include emergence of advanced 3d printing techniques, development of multifunctional bioceramic materials, utilization of nanotechnology in bioceramic design, introduction of antibacterial bioceramics, focus on bioresorbable bioceramics for temporary implants, advancements in bioceramic coatings for implants.

The forecast of 6.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. orthopedic surgery by inflating prices of hydroxyapatite bone grafts and dental implant materials developed in Brazil and Germany, resulting in delayed reconstructive procedures and higher implant surgery expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of orthopedic and dental disorders is projected to drive the growth of the bioceramics market in the future. Orthopedic and dental disorders are two distinct types of medical conditions, with orthopedic disorders primarily affecting the musculoskeletal system and dental disorders impacting oral health and the structures within the mouth. Bioceramics are extensively used in both orthopedics and dentistry due to their biocompatibility, durability, and ability to mimic the properties of natural bones and teeth. In orthopedics, they are commonly utilized for implantation, such as in hip and knee joint replacements. Similarly, in dentistry, bioceramics are widely applied in various dental restorations, including crowns, bridges, and dental implants. For instance, in July 2022, the UK Health Security, a public health government agency, reported a notable 10.2% increase in mandatory orthopedic procedure submissions, reaching 102,025 for the financial year 2022 to 2023. Additionally, in March 2023, the World Health Organization, a Switzerland-based government organization, estimated that oral diseases affect nearly 3.5 billion people globally in 2022. Furthermore, in February 2024, the British Dental Association, a UK-based health organization, reported that over 12 million adults in England have unmet dental needs. Thus, the growing prevalence of orthopedic and dental disorders is expected to boost the bioceramics market.

The increasing incidence of cardiovascular diseases is anticipated to fuel the growth of the bioceramics market in the coming years. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease, cerebrovascular disease, peripheral arterial disease, and aortic atherosclerosis. Bioceramics play a crucial role in the context of cardiovascular diseases by serving as implantable materials in medical devices such as artificial heart valves and stents, enhancing biocompatibility and durability in cardiac interventions. For example, in September 2024, a report from the British Heart Foundation (BHF), a UK-based charity that funds research and promotes awareness about heart and circulatory diseases, indicated that around 7.6 million individuals in the UK are affected by heart and circulatory diseases. By 2030, the number of individuals living with these diseases in the UK could increase by an additional 1 million, with a further rise of 2 million expected by 2040, on top of current figures. Therefore, the increasing incidence of cardiovascular diseases is propelling the growth of the bioceramics market.

Leading companies in the bioceramics market are introducing advanced materials such as LithaBone HA 480 to enhance bioceramic implants' performance and the quality of 3D-printed bone implants. LithaBone HA 480, a hydroxyapatite (HA) type, is designed for the production of patient-specific ceramic implants, offering improved wall thickness and enhanced geometric flexibility. The launch of this innovative material by Lithoz GmbH showcases the commitment to revolutionize bone implant manufacturing, making them more effective, affordable, and accessible for diverse medical applications such as bone grafts, dental implants, and orthopedic prostheses.

In July 2023, SHS Gesellschaft fur Beteiligungsmanagement mbH, a Germany-based independent private equity firm, successfully acquired a majority stake in CAM Bioceramics for an undisclosed sum. This strategic acquisition is geared toward fortifying and expanding SHS's presence in the realm of innovative calcium phosphate solutions within the medical industry. The move is anticipated to propel the company's growth and success in the burgeoning bioceramics market. CAM Bioceramics, headquartered in the Netherlands, specializes in the manufacturing of bioceramics for applications in the medical and healthcare sectors.

Major companies operating in the bioceramics market report are Stryker Corporation, Kyocera Corporation, The Royal DSM Company, Zimmer-Biomet Holdings Inc., Dentsply Sirona, NGK Spark Plug Co. Ltd., Straumann Group, Morgan Advanced Materials PLC, CoorsTek Medical, Carborundum Universal Ltd., Washington Mills Ceramics Corporation, Saint-Gobain Ceramics And Plastics Inc., H.C. Starck Ceramics GmbH, Nobel Biocare Holding AG, Ceram Tec, Nabertherm GmbH., Collagen Matrix Inc., DePuy Synthes Inc., CamBioceramics, Sagemax Bioceramics, Astro Met Inc., Bonesupport AB, Berkeley Advanced BioTypes Inc., Matexcel, Jyoti Ceramic Industries Pvt. Ltd., Doceram Medical Ceramics GmbH, Amedica Corporation, BIOMATCAN Ltd., CaP Biomaterials LLC, IJ Research Inc.

North America was the largest region in the bioceramics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioceramics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioceramics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioceramics market consists of sales of bio-conductive ceramics, piezoelectric ceramics, radiopaque ceramics and composite bioceramics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioceramics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioceramics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bioceramics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioceramics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Bioceramics Market Characteristics

3. Bioceramics Market Trends And Strategies

4. Bioceramics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bioceramics Growth Analysis And Strategic Analysis Framework

6. Bioceramics Market Segmentation

7. Bioceramics Market Regional And Country Analysis

8. Asia-Pacific Bioceramics Market

9. China Bioceramics Market

10. India Bioceramics Market

11. Japan Bioceramics Market

12. Australia Bioceramics Market

13. Indonesia Bioceramics Market

14. South Korea Bioceramics Market

15. Western Europe Bioceramics Market

16. UK Bioceramics Market

17. Germany Bioceramics Market

18. France Bioceramics Market

19. Italy Bioceramics Market

20. Spain Bioceramics Market

21. Eastern Europe Bioceramics Market

22. Russia Bioceramics Market

23. North America Bioceramics Market

24. USA Bioceramics Market

25. Canada Bioceramics Market

26. South America Bioceramics Market

27. Brazil Bioceramics Market

28. Middle East Bioceramics Market

29. Africa Bioceramics Market

30. Bioceramics Market Competitive Landscape And Company Profiles

31. Bioceramics Market Other Major And Innovative Companies

32. Global Bioceramics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioceramics Market

34. Recent Developments In The Bioceramics Market

35. Bioceramics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기